Private Advisor Group LLC raised its position in Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report) by 26.4% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 35,645 shares of the medical equipment provider’s stock after acquiring an additional 7,448 shares during the quarter. Private Advisor Group LLC’s holdings in Intuitive Surgical were worth $14,494,000 as of its most recent SEC filing.
Other institutional investors and hedge funds also recently bought and sold shares of the company. VIRGINIA RETIREMENT SYSTEMS ET Al purchased a new stake in Intuitive Surgical during the second quarter valued at about $14,316,000. Plato Investment Management Ltd purchased a new position in shares of Intuitive Surgical in the 2nd quarter worth about $4,315,000. Hikari Power Ltd purchased a new position in shares of Intuitive Surgical in the 2nd quarter worth about $5,619,000. NewEdge Advisors LLC increased its position in shares of Intuitive Surgical by 19.1% during the 2nd quarter. NewEdge Advisors LLC now owns 50,825 shares of the medical equipment provider’s stock valued at $20,212,000 after purchasing an additional 8,142 shares during the last quarter. Finally, Concurrent Investment Advisors LLC grew its position in Intuitive Surgical by 30.8% during the second quarter. Concurrent Investment Advisors LLC now owns 25,639 shares of the medical equipment provider’s stock valued at $10,196,000 after acquiring an additional 6,043 shares during the last quarter. 83.64% of the stock is currently owned by hedge funds and other institutional investors.
Intuitive Surgical Stock Performance
Shares of Intuitive Surgical stock opened at $399.06 on Friday. Intuitive Surgical, Inc. has a 52-week low of $328.57 and a 52-week high of $603.88. The stock has a market capitalization of $138.33 billion, a price-to-earnings ratio of 48.25, a P/E/G ratio of 3.02 and a beta of 1.45. The company’s 50 day moving average price is $423.51 and its 200-day moving average price is $427.91.
Intuitive Surgical (NASDAQ:ISRG – Get Free Report) last posted its quarterly earnings results on Tuesday, October 20th. The medical equipment provider reported $3.00 EPS for the quarter, beating analysts’ consensus estimates of $2.65 by $0.35. The company had revenue of $3.05 billion during the quarter, compared to analyst estimates of $2.91 billion. Intuitive Surgical had a net margin of 25.54% and a return on equity of 18.17%. The firm’s revenue was up 21.7% compared to the same quarter last year. During the same period in the prior year, the business posted $2.40 EPS. As a group, equities research analysts forecast that Intuitive Surgical, Inc. will post 9.37 earnings per share for the current fiscal year.
Latest Intuitive Surgical News
Investors following ISRG have been watching these news items:
- Positive Sentiment: A BTIG Research analyst reportedly expects ISRG shares to rise, providing a positive analyst signal; the headline does not specify a price target or the reasoning. BTIG analyst article
- Positive Sentiment: Industry coverage casts Intuitive Surgical as a leading beneficiary of expanding surgical-robotics adoption, citing growth in robotic procedures and use of its da Vinci system. A separate medical-device roundup also identifies ISRG as a stock to watch, though neither story reports a new company announcement. Surgical robotics industry article Medical-device stocks article
- Negative Sentiment: ISRG was reported down 1.7% since its latest earnings report, suggesting the strong results have not yet translated into sustained share-price momentum. The article offers no fresh earnings-estimate change to clarify the potential for a rebound. Post-earnings performance article
Analyst Ratings Changes
A number of equities analysts recently commented on ISRG shares. BNP Paribas Exane upgraded shares of Intuitive Surgical to an “outperform” rating in a research report on Tuesday, July 28th. UBS Group restated a “buy” rating on shares of Intuitive Surgical in a research report on Tuesday, October 13th. JPMorgan Chase & Co. raised their price objective on Intuitive Surgical from $450.00 to $475.00 and gave the company an “overweight” rating in a research note on Wednesday, October 21st. BTIG Research lifted their price objective on Intuitive Surgical from $454.00 to $513.00 and gave the stock a “buy” rating in a report on Wednesday. Finally, Royal Bank Of Canada lowered their target price on Intuitive Surgical from $575.00 to $550.00 and set an “outperform” rating for the company in a research note on Wednesday, October 21st. One research analyst has rated the stock with a Strong Buy rating, twenty-three have issued a Buy rating, five have given a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, Intuitive Surgical currently has an average rating of “Moderate Buy” and an average target price of $495.90.
Insiders Place Their Bets
In other news, Director Gary S. Guthart sold 10,000 shares of the stock in a transaction dated Wednesday, November 4th. The shares were sold at an average price of $457.34, for a total transaction of $4,573,400.00. Following the completion of the sale, the director directly owned 1,194,530 shares in the company, valued at approximately $546,306,350.20. This represents a 0.83% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Gary Loeb sold 400 shares of the business’s stock in a transaction dated Tuesday, November 10th. The shares were sold at an average price of $458.15, for a total value of $183,260.00. Following the transaction, the executive vice president owned 6,236 shares in the company, valued at approximately $2,857,023.40. This represents a 6.03% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last 90 days, insiders have sold 39,363 shares of company stock worth $17,738,749. 0.60% of the stock is currently owned by insiders.
Intuitive Surgical Company Profile
Intuitive Surgical develops, manufactures and markets robotic-assisted systems for minimally invasive procedures. Its products include da Vinci surgical systems, which allow surgeons to control instruments and a high-definition vision system from a console, as well as the Ion endoluminal system, designed to assist with minimally invasive lung biopsies. The company also provides instruments, accessories, training and support services for its systems. Its technology is used in a range of surgical specialties, including urology, general surgery and gynecology.
Read More
- Five stocks we like better than Intuitive Surgical
- MarketBeat Week in Review – 11/16 – 11/20
- Survey Reveals: How Much Would People Pay for Ribeye Before Giving It Up? [2026]
- If NVIDIA Tightens Its Wallet, These 3 Stocks Could Feel It
- 3 Dividend ETFs Offering Steadier Footing in a Shaky Market
Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report).
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.
